Income Statement (Annual)

CAA / CalAtlantic Group, Inc. Short Interest

CAA / CalAtlantic Group, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Adminstrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000 except per share units.

2009 2010 2011 2012 2013 2014 2015 2016
Construction Revenue
  Home Building Revenue 1,060,502 908,562 882,094 1,190,252 1,898,989 2,366,754 3,449,047 6,354,869
  Land Sales 105,895 3,856 899 46,706 15,620 44,424 47,364 33,171
  Real Estate Revenue Net 1,166,397 912,418 882,993 1,236,958 1,914,609 2,411,178 3,496,411 6,388,040
  Home Building Costs 907,058 707,006 719,893 946,630 1,431,797 1,748,954 2,676,666 4,967,278
  Costs Of Real Estate Services And Land Sales 117,517 3,568 903 46,654 13,616 43,841 43,274 30,132
  Cost Of Real Estate Revenue 1,024,575 710,574 720,796 993,284 1,445,413 1,792,795 2,719,940 4,997,410
  Gross Profit 141,822 201,844 162,197 243,674 469,196 618,383 776,471 1,390,630
  Selling General And Administrative Expense 191,488 150,542 154,375 172,207 230,691 275,861 390,710 664,459
  Income Loss From Equity Method Investments -4,598 1,166 207 -2,090 949 -668 1,966 4,057
  Other Nonoperating Income Expense -2,296 3,733 -1,017 4,664 6,815 -1,733 -62,177 -16,726
  Homebuilding Pretax Income Or Loss -111,068 -14,001 -18,156 67,645 246,269 340,121 325,550 713,502
Financial Services Revenue
  Financial Services Revenue 13,145 12,456 10,907 21,300 24,910 24,119 43,702 88,695
  Financial Services Costs 11,817 10,878 9,401 11,062 14,159 15,245 26,763 49,081
  Financial Services Pretax Income Or Loss 1,586 1,720 1,683 10,542 11,429 9,843 16,939 39,614
  Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest -109,482 -12,281 -16,473 78,187 257,698 349,964 342,489 753,116
  Income Tax Expense Benefit -96,265 -557 -56 -453,234 68,983 134,099 128,980 268,386
  Net Income Loss -13,786 -11,724 -16,417 531,421 188,715 215,865 213,509 484,730
  Net Income Loss Allocated To Unvested Restricted Stock - - - 410 265 297 369 1,168
  Net Income Loss Available To Common Stockholders Basic -5,415 -4,875 -9,316 306,603 131,064 163,918 180,143 483,562
Earnings Per Share
  Earnings Per Share Basic -0 -0 -0 0 0 0 0 0
  Earnings Per Share Diluted -0 -0 -0 0 0 0 0 0
Weighted Average Number Of Shares Outstanding Diluted Disclosure Items
  Weighted Average Number Of Shares Outstanding Basic 95,624 105,203 193,910 201,954 253,118 278,688 71,714 118,213
  Weighted Average Number Of Diluted Shares Outstanding 95,624 105,203 193,910 220,519 291,174 316,285 81,513 135,985
  Common Stock Dividends Per Share Declared - - - - - - 0 -

Peers - Operative Builders (1531)

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

CUSIP: 128195104